An Innovative Multidisciplinary Study of The Availability of Coronavirus Vaccines in The World
DOI:
https://doi.org/10.53933/sspmpm.v2i2.45Keywords:
COVID-19, coronavirus epidemic, vaccines, innovative technologies, multidisciplinary research, evidence-based medicine, evidence-based pharmacy, content analysis, personalized vaccinationAbstract
The article presents the results of the search for innovative technologies in a multidisciplinary study of the availability of COVID-19 vaccines of any type in the world. In the context of the coronavirus pandemic, multidisciplinary health research brings together the interdisciplinary links of scientists from around the world in medicine, pharmacy, law, economics on good medical practice, pharmaceutical provision and vaccination availability for all contingent of patients and postcovid health disorders. The aim of the research was to search for innovative technologies for the study of medically approved vaccines against COVID-19 in countries around the world using a multidisciplinary and integrated approach in the application of traditional and new methods of analysis. Content analysis was performed according to the range of licenses, permits for medical use and manufacturers by grouping them using the Sturgess formula, followed by construction of a discrete series of variations and distribution polygon. The results show satisfactory availability of vaccines against COVID-19 of any type. Doctors have a choice of appropriate vaccines and the manufacturer that corresponds to the social personalized vaccination taking into account the individual characteristics of patients.
References
Shapovalova V.A., Zbrozhek S.I., Shapоvalov V.V. et al. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4. Iss. 7. P. 61–68. URL: https://www.actascientific.com/ASPS/ASPS-04-0559.php. DOI: https://doi.org/10.31080/ASPS.2020.04.0559
Shapovalov V. (Jr.), Zbrozhek S., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol. 51. N. 1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
Chuiev Y., Shapovalova V. Interdisciplinary pharmacoeconomic study of pharmacotherapy of cupping of drunk forms of alcohol dependence: clinical and pharmacological, organizational, legal and marketing experiment. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.24. DOI: https://doi.org/10.53933/sspmpm.v1i2.24
Zbrozgek S. Reform of the healthcare system as a basis for streamlining the organization of circulation and availability of medicines for patients in the context of the COVID-19 pandemic. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. No. 2. P. 1-32. URL: https://doi.org/10.53933/sspmpm.v1i2.31. DOI: https://doi.org/10.53933/sspmpm.v1i2.31
Hayduchok І. Рharmacotherapy of systemic autoimmune diseases in conditions of the COVID-19 pandemic: innovative experimental study. Science Review. 2021. Vol. 3. No. 38. P. 1-7. DOI:10.31435/rsglobal_sr/30072021/7619. DOI: https://doi.org/10.31435/rsglobal_sr/30072021/7619
Hayduchok І., Shapovalov V. Covid-19: multidisciplinary researches of forensic and pharmaceutical risks and causal relationships of unqualified medical care for patients during pandemic. 2022. SSP Modern Law and Practice. Vol.2. N.1. P.1-25. URL: https://doi.org/10.53933/sspmlp.v2i1.39. DOI: https://doi.org/10.53933/sspmlp.v2i1.39
COVID pandemic fuelling major increase in drug use worldwide: UN report. United Nations. URL: https://news.un.org/en/story/2021/06/1094672.
WHO designates new COVID strain Omicron as ‘variant of concern’. Gur Times. URL: https://gurtimes.com/business/who-designates-new-covid-strain-omicron-as-variant-of-concern/.
WHO designates new COVID strain Omicron as ‘variant of concern’. Aljazeera. URL: https://www.aljazeera.com/news/2021/11/26/who-designates-new-covid-strain-omicron-variant-of-concern.
CDC Expands Eligibility for COVID-19 Booster Shots to All Adults. CDC. 19.11.2021. URL:https://www.cdc.gov/media/releases/2021/s1119-booster-shots.html.
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters. EMA. 10.04.2021. URL: https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters.
Duqueroy V. Should Everyone Get a COVID-19 Vaccine Booster? Medscape. November 25, 2021. URL:https://www.medscape.com/viewarticle/963683.
Booster vaccination: why it is so important, despite the fact that vaccinated Israel continues to get sick. TSN. 03.12.2021. URL: https://tsn.ua/svit/busterne-scheplennya-chomu-vono-duzhe-vazhlive-popri-te-scho-vakcinovaniy-izrayil-prodovzhuye-hvoriti-1922848.html.
Omicron Spreading in U.S.; Gilead Recalls Vials: Virus Update. Bloomberg News. 03.12.2021. URL:https://www.bloomberg.com/news/articles/2021-12-03/omicron-in-eight-u-s-states-south-africa-surges-virus-update.
«Third dose of the vaccine is extremely efficient» Israeli study: COVID booster shots 92% effective at preventing serious illness. The Times of Israel. 30.10.2021. URL: https://www.timesofisrael.com/israeli-study-covid-booster-shots-92-effective-at-preventing-serious-illness/.
Barda N., Dagan N., Cohen C. et. al. Effectiveness of a third dose of the bnt162b2 mrna COVID-19 vaccine for preventing severe outcomes in Israel: an observational stugy. The Lancet. 04.12.2021. Vol. 398. Iss. 10316. Р. 2093-2100. URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext. DOI: https://doi.org/10.1016/S0140-6736(21)02249-2
Barbash G. Half of serious COVID-19 cases fully vaccinated. Arutz Sheva. 08.07.2021. URL:https://www.israelnationalnews.com/News/News.aspx/309494.
Wang Y., Pan X., Baі Y. The Experience of рatients with COVID-19 in China: аn іnterpretative рhenomenological аnalysis. PRBM. 28.06.2021. Vol.2021. N.14. Р. 877-887.DOI: https://doi.org/10.2147/PRBM.S310266. DOI: https://doi.org/10.2147/PRBM.S310266
The WHO called the overall global risk of a new coronavirus strain "very high". Radio Svoboda. 30.11.2021. URL: https://www.radiosvoboda.org/a/news-omikron-vooz-ryzyky/31586271.html.
Bratushchyk-Homa M. Very high risk of outbreaks: in which countries Omicron has been detected and whether vaccines are effective against it. Ukr. tyzhden. 30.11.2021. URL: https://tyzhden.ua/Pandemic/253756.
Occupational burnout is a phenomenon, not a disease: What was actually approved in ICD-11. Ministry of Health of Ukraine. URL: https://moz.gov.ua/article/news/profesijne-vigorannja---javische-a-ne-hvoroba-scho-naspravdi-zatverdili-v-mkh-11.
Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. N.1. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37. DOI: https://doi.org/10.53933/sspmpm.v2i1.37
Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. Development of forensic and pharmaceutical researches within the organization of pharmaceutical business, drug technology and pharmaceutical law in Ukraine concerning the turnover of controlled drugs and substances. Health of Society. 2021. Vol. 10. N. 3. P. 98-106. DOI: https://doi.org/10.22141/2306-2436.10.3.2021.246351. DOI: https://doi.org/10.22141/2306-2436.10.3.2021.246351
Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. Forensic and pharmaceutical research on the impact of drugs on the safety, life and health of road users within the organization of pharmaceutical business, drug technology, pharmaceutical and medical law in Ukraine. Health of Society. 2021. Vol. 10. N. 4. P. 127-132. DOI: https://doi.org/10.22141/2306-2436.10.4.2021.246355. DOI: https://doi.org/10.22141/2306-2436.10.4.2021.246355
Shapovalova V., Zakharchenko I. Organizational and legal approaches to reforming of the law enforcement system of Ukraine: illegal circulation of psychoactive substances and addictive dependence. 2021. SSP Modern Law and Practice. Vol. 1. N.1. P.1–22. URL: https://doi.org/10.53933/sspmlp.v1i1.20. DOI: https://doi.org/10.53933/sspmlp.v1i1.20
Shapovalov (Jr.) V., Gudzenko A., Shapovalova V., Shapovalov V.. Forensic and pharmaceutical analysis of addictive morbidity because of the use of narcotic psychoactive substances in Ukraine (retrospective aspect). International Journal of Pharmaceutical Sciences and Research. 2018. Vol. 3. Is.3. July 2018. P.22-25. URL: http://www.pharmacyjournal.net/archives/2018/vol3/issue3.
Shapovalova V.A., Shapovalov V.V. The clinical efficacy of the combined drug agent Valcophen in children. Likars'ka sprava. 1999. N.1. P.124–126.
Shapovalova V.O., Mykhailov V.S., Shapovalov V.V. The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice. Fiziolohichnyi zhurnal. 1999. Vol.45. N.3. P 114–117.
Shapovalova V.O., Shapovalov V.V. Spasmophilia in children and the anticonvulsant properties of a new Ukrainian preparation containing a pyrimidine derivative. Fiziolohichnyi zhurnal. 1998. Vol.44. N.5-6. P. 102–105. DOI: https://doi.org/10.1049/ir:19980309
Shapovalova V.O., Chernykh V.P. The physiological properties of the action of a new analgesic and antipyretic preparation. Fiziolohichnyi zhurnal. 1997. Vol.43. N.1-2. P. 117–121.
Shapovalov V. (Jr.), Gudzenko А., Komar L. et al. Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia. 2017. Vol. 65. N. 2. P. 23–29. URL: http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.
Shapovalov V. (Jr.), Gudzenko A., Shapovalova V. at. el. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol. 66. N. 3. Р. 31–39. URL: http://bsphs.org/wp-content/uploads/2017/11/Shapovalov.pdf.
Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients Pharmacia. 2018. Vol. 65. N. 2. P. 17-22. URL: http://bsphs.org/?magasine=organizational-and-legal-evaluation-of-availability-of-medicines-circulation-for-cancer-patients.
McGill L. Patient safety: a European Union priority. Clin Med (Lond). 2009. Vol. 9. N.2. Р. 136-139. DOI: 10.7861/clinmedicine.9-2-136. URL: https://pubmed.ncbi.nlm.nih.gov/19435118/. DOI: https://doi.org/10.7861/clinmedicine.9-2-136
Tukhar I., Shapovalova V., Shapovalov V. et al. Pharmacological view on the problem of comorbidity in the pharmacotherapy of chronic pancreatitis. Science Review. Vol. 3. No. 38. P. 1-5. DOI: 10.31435/rsglobal_sr/30072021/7591. DOI: https://doi.org/10.31435/rsglobal_sr/30072021/7591
Shapovalov V., Butko L., Shapovalov V. Organizational and legal study of quarantine restrictions in the spread of coronavirus disease in Ukraine. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.23. DOI: https://doi.org/10.53933/sspmpm.v1i2.23
ICD-11 for Mortality and Morbidity Statistics (Version: 05/2021). URL: https://icd.who.int/browse11/l-m/en.
Reed G.M., First M.B., Kogan C.S. еt al. Innovations and changes in the ICD-11 classification of mental, behavioral and neurodevelopmental disorders. Wiley Online Library. 02 January 2019. URL: https://doi.org/10.1002/wps.20611. DOI: https://doi.org/10.1002/wps.20611
Harrison J.E., Weber S., Jakob R. et al. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inform Decis Mak. 2021. N.21. 206 p. URL: https://doi.org/10.1186/s12911-021-01534-6. DOI: https://doi.org/10.1186/s12911-021-01534-6
Shapovalova V.O., Zbrozhek S.I., Shapovalov V.V. (Jr.) et al. Content analysis of pharmacies in Ukraine, which produce extemporaneous drugs. Public health. 2017. T.6. N.3–4. P.77–83. DOI: 10.22141/2306-2436.6.3.2017.123498. DOI: https://doi.org/10.22141/2306-2436.6.3.2017.123498
Shapovalova V.O. et al. Content analysis of alcohol circulation in healthcare facilities at the stage of budget procurement. Copyright No. 79456 (In Ukrainian). Publ. 05/31/18.
Gudzenko A.A., Osyntseva A.A., Shapovalova V.O. Content analysis of the circulation of alcoholic drugs by dosage form and registration certificates. Copyright 79473 (In Ukrainian). Publ. 06/01/18.
Anhui Zhifei. Longcom ZF2001. Approved Vaccines. URL: https://covid19.trackvaccines.org/vaccines/approved/#vaccine-list.
Vaccination, approval and trial rates by country. Last updated: January 24, 2022. URL: https://covid19.trackvaccines.org/trials-vaccines-by-country/#approvals.
Hsieh Hsiu-Fang et al. Three аpproaches to qualitative content analysis. ResearchGate (2005). DOI: 10.1177/1049732305276687. URL: https://www.researchgate.net/publication/7561647_Three_Approaches_to_Qualitative_Content_Analysis.
Le J. K. et al. The Practice of innovating research methods. Sage Journal. 2020. URL: https://journals.sagepub.com/doi/10.1177/1094428120935498.
Hayduchok I. G. Innovation approaches to pharmacotherapy of systemic autoimmune diseases in the conditions of the COVID-19 pandemic. Likars’ka Sprava. 2020. N. 7–8. P. 64-74. DOI: 10.31640/JVD.7-8.2020 (8).
Davis J. Content analysis of efficacy descriptions on branded pharmaceutical websites. Journal of Medical Marketing. 2012. Vol.12. N.4. P. 211-220. DOI: 10.1177/1745790412465425. DOI: https://doi.org/10.1177/1745790412465425
Awaisu A. et al. Research designs and methodologies related to pharmacy practice. Encyclopedia of pharmacy practice and clinical pharmacy. 2019. P. 7–21. DOI: 10.1016/B978-0-12-812735-3.00602-6.
Hayduchok I.G. Innovation approaches to pharmacotherapy of systemic autoimmune diseases in the conditions of the COVID-19 pandemic. Likars’ka Sprava. 2020. N. 7–8. P. 64-74. DOI: 10.31640/JVD.7-8.2020 (8). DOI: https://doi.org/10.31640/JVD.7-8.2020(8)
Christy J. et al. Content analysis of internet marketing strategies: how pharmaceutical companies communicate about contraceptives with consumers online. J. Med. Internet Res. 2009. URL: https://journals.sagepub.com/doi/abs/10.1080/15245000903038308.
Hayduchok I. Pharmacotherapy of systemic autoimmune diseases in the сonvention of the COVID-19 pandemic: search for innovative technologies in the study. Acta Scientific Medical Science. 2021. Vol. 5. Iss. 9. P. 136-142. DOI: 10.31080/ASMS.2020.05.1022 DOI: https://doi.org/10.31080/ASMS.2020.05.1022
COVID pandemic fuelling major increase in drug use worldwide: UN report. United Nations. URL: https://news.un.org/en/story/2021/06/1094672.
Data and statistics. WHO euro. 24.19.2021. URL: https://www.euro.who.int/en/health-topics/Health-systems/patient-safety/data-and-statistics.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Viktoriia Shapovalova
This work is licensed under a Creative Commons Attribution 4.0 International License.
